ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate CAS:212322-56-0

Antibacterial Agent: Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate exhibits antibacterial properties, making it valuable in the development of antibiotics and antiseptics. Its ability to inhibit bacterial growth and disrupt cellular processes positions it as a key component in combating infectious diseases caused by pathogenic bacteria. Anti-inflammatory Medication: Due to its anti-inflammatory properties, Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate can be incorporated into pharmaceuticals aimed at managing inflammatory conditions such as arthritis, dermatitis, and inflammatory bowel diseases. By reducing inflammation, it helps alleviate pain and swelling associated with these conditions. Pain Management: This compound may be used in analgesic medications to help manage moderate to severe pain. Its interaction with pain receptors and neurotransmitters in the body can provide relief for individuals suffering from acute or chronic pain, enhancing their quality of life. Antiviral Treatment: Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate's antiviral properties make it a promising candidate for developing medications targeting viral infections. By interfering with viral replication and assembly, it has the potential to combat a broad spectrum of viruses, contributing to the advancement of antiviral therapies. Dermatological Applications: In dermatology, this ingredient can be utilized in formulations for treating skin conditions such as acne, eczema, and psoriasis. Its antibacterial and anti-inflammatory characteristics make it beneficial for addressing these dermatological concerns, promoting skin health and comfort. Neurological Disorders: Research suggests that Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate may offer therapeutic benefits for certain neurological disorders, including Alzheimer's disease and Parkinson's disease. Its neuroprotective properties and potential to modulate neural pathways make it an area of interest for further exploration in neurology. When incorporating Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate into pharmaceutical products, adherence to dosage recommendations and safety considerations is crucial. Furthermore, consultation with healthcare professionals and compliance with regulatory guidelines are essential to ensure the safe and effective use of medications containing this active ingredient.